Dr. Levine is a member of the Human Oncology and Pathogenesis Program and an attending physician on the Leukemia Service, Department of Medicine, the Laurence Joseph Dineen Chair in Leukemia Research with Special Emphasis on Leukemia in Children and Young People, Deputy Physician-In-Chief, Translational Research at MSK, and a professor of Medicine at Weill Cornell Medical College. His laboratory has identified myeloproliferative neoplasm (MPN) predisposition alleles and characterized somatic genetic and epigenetic alterations in MPN and acute myeloid leukemia (AML) patients, which has led to new mechanism-based therapies. In 2011, Dr. Levine was elected to the American Society of Clinical Investigation and in 2018 to the Association of American Physicians. Dr. Levine is the recipient of numerous awards, including the Dameshek Prize from the American Society for Hematology, a Scholar Award from the Leukemia and Lymphoma Society, the Boyer Award for clinical investigation from Memorial Sloan Kettering Cancer Center, and an NCI Outstanding Investigator Award. Dr. Levine earned his A.B. from Harvard College and a M.D. from Johns Hopkins University.